LH
Labcorp Holdings Inc.
Diagnostics & Research · Healthcare · United States
322.59
close · 2026-08-13
value
95
cheaper than peers95
quality
35
stronger fundamentals35
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 16.31× | 97 |
| EV to EBITDA | 13.58× | 91 |
| price to sales | 1.77× | 91 |
| price to book | 3.03× | 67 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 11.7% | 63 |
| operating margin | 12.2% | 54 |
| debt to equity | 78.5% | 37 |
| revenue growth | 5.8% | 23 |
4 of 4 measures available
Facts
| market cap | $26B |
| free cash flow | $892.0M |
| employees | 71,000 |
| first trade | 1990-03-29 |
| next earnings | 2026-07-30 |
| fundamentals updated | 2026-08-05 |